Ranibizumab treatment history as predictor of the switch-response to aflibercept: evidence for drug tolerance

Ali Dirani, Irmela Mantel Department of Ophthalmology, University of Lausanne, Jules Gonin Eye Hospital, Fondation Asile des Aveugles, Lausanne, Switzerland Purpose: To investigate whether tolerance to the anti-VEGF drug, ranibizumab, develops after drug exposure and to determine whether the histo...

Full description

Bibliographic Details
Main Authors: Dirani A, Mantel I
Format: Article
Language:English
Published: Dove Medical Press 2018-03-01
Series:Clinical Ophthalmology
Subjects:
Online Access:https://www.dovepress.com/ranibizumab-treatment-history-as-predictor-of-the-switch-response-to-a-peer-reviewed-article-OPTH